Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 22, Pages 5698
Publisher
MDPI AG
Online
2019-11-14
DOI
10.3390/ijms20225698
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy
- (2019) Zheng Qiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reprint of “Immunomodulatory effects of CD38-targeting antibodies”
- (2019) Niels W.C.J. van de Donk IMMUNOLOGY LETTERS
- Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer
- (2019) Hongmei Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
- (2019) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling
- (2019) Angela Yan et al. JOURNAL OF NEUROSCIENCE
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
- (2019) Simone de Leve et al. Frontiers in Immunology
- Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach
- (2019) J. H. Azambuja et al. MOLECULAR NEUROBIOLOGY
- Immunologic and immunogenomic aspects of tumor progression
- (2019) Andrea Ladányi et al. SEMINARS IN CANCER BIOLOGY
- Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
- (2018) Tao Jiang et al. BMC CANCER
- T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients
- (2018) P. Di Gennaro et al. CANCER LETTERS
- Modulation of innate and adaptive immunity by P2X ion channels
- (2018) Francesco Di Virgilio et al. CURRENT OPINION IN IMMUNOLOGY
- Adenosine signaling and the immune system: When a lot could be too much
- (2018) Luca Antonioli et al. IMMUNOLOGY LETTERS
- Targeting the CD73-adenosine axis in immuno-oncology
- (2018) David Allard et al. IMMUNOLOGY LETTERS
- Canonical and non-canonical adenosinergic pathways
- (2018) E. Ferretti et al. IMMUNOLOGY LETTERS
- A2AAdenosine Receptor Gene Deletion or Synthetic A2AAntagonist Liberate Tumor-Reactive CD8+T Cells from Tumor-Induced Immunosuppression
- (2018) Jorgen Kjaergaard et al. JOURNAL OF IMMUNOLOGY
- Pharmacology of Adenosine Receptors: The State of the Art
- (2018) Pier Andrea Borea et al. PHYSIOLOGICAL REVIEWS
- Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+
- (2018) F. Morandi et al. OncoImmunology
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence
- (2018) M.-N. Theodoraki et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
- (2018) J. H. Azambuja et al. MOLECULAR NEUROBIOLOGY
- Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection
- (2018) Daniela F. Passos et al. Purinergic Signalling
- Extracellular nucleotides and nucleosides as signalling molecules
- (2018) Anna Lisa Giuliani et al. IMMUNOLOGY LETTERS
- Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
- (2018) Kevin Sek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
- (2018) Andrea M. Chambers et al. Frontiers in Immunology
- Cellular Migration Ability Is Modulated by Extracellular Purines in Ovarian Carcinoma SKOV-3 Cells
- (2017) A.S. Martínez-Ramírez et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
- (2017) Farhad Jadidi-Niaragh et al. JOURNAL OF CONTROLLED RELEASE
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
- (2017) Samaneh Arab et al. TUMOR BIOLOGY
- A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation
- (2017) Seyyed Mehdi Jafari et al. CELLULAR ONCOLOGY
- Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
- (2016) J. Krejcik et al. BLOOD
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- The A 2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism
- (2016) Christina Mølck et al. CANCER LETTERS
- Immunosuppressive activities of adenosine in cancer
- (2016) Bertrand Allard et al. CURRENT OPINION IN PHARMACOLOGY
- Purinergic Signalling and Endothelium
- (2016) Geoffrey Burnstock Current Vascular Pharmacology
- Exosomes and tumor-mediated immune suppression
- (2016) Theresa L. Whiteside JOURNAL OF CLINICAL INVESTIGATION
- CD73 Inhibition Shifts Cardiac Macrophage Polarization toward a Microbicidal Phenotype and Ameliorates the Outcome of Experimental Chagas Cardiomyopathy
- (2016) Nicolás Eric Ponce et al. JOURNAL OF IMMUNOLOGY
- Extracellular purines, purinergic receptors and tumor growth
- (2016) F Di Virgilio et al. ONCOGENE
- Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration
- (2016) Patrycja Koszałka et al. PLoS One
- Adenosine arrests breast cancer cell motility by A3 receptor stimulation
- (2016) Carola Ledderose et al. Purinergic Signalling
- Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
- (2016) Farhad Jadidi-Niaragh et al. TUMOR BIOLOGY
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
- (2016) Itsaso Montalbán del Barrio et al. Journal for ImmunoTherapy of Cancer
- Adenosine A2b receptor promotes progression of human oral cancer
- (2015) Hiroki Kasama et al. BMC CANCER
- P2X Receptors and Inflammation
- (2015) Francesco Virgilio CURRENT MEDICINAL CHEMISTRY
- Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium
- (2015) Letícia Scussel Bergamin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Purinergic signalling during development and ageing
- (2015) Geoffrey Burnstock et al. Purinergic Signalling
- Blood cells: an historical account of the roles of purinergic signalling
- (2015) Geoffrey Burnstock Purinergic Signalling
- The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma
- (2015) Bin Zhang et al. TUMOR BIOLOGY
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- Ecto-5’-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model
- (2015) Angélica R. Cappellari et al. PLoS One
- A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin
- (2015) Stefania Merighi et al. NEOPLASIA
- Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
- (2015) Raffaella Iannone et al. NEOPLASIA
- Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
- (2014) D. Mittal et al. CANCER RESEARCH
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Macrophage heterogeneity in tissues: phenotypic diversity and functions
- (2014) Siamon Gordon et al. IMMUNOLOGICAL REVIEWS
- CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis
- (2014) A. Mikhailov et al. JOURNAL OF IMMUNOLOGY
- Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors
- (2014) Ester Sciaraffia et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells
- (2014) Wakako Kaji et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Purinergic signalling and immune cells
- (2014) Geoffrey Burnstock et al. Purinergic Signalling
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
- (2013) Melanie Mediavilla-Varela et al. CANCER BIOLOGY & THERAPY
- CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+T cells contributes to their regulatory function
- (2013) Lesley Ann Smyth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
- (2013) Christopher James Ferrante et al. INFLAMMATION
- Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
- (2013) M. G. Terp et al. JOURNAL OF IMMUNOLOGY
- Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo
- (2013) PATRYCJA KOSZAŁKA et al. ONCOLOGY REPORTS
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purinergic signalling in the reproductive system in health and disease
- (2013) Geoffrey Burnstock Purinergic Signalling
- Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms
- (2013) Anke C. Schiedel et al. Purinergic Signalling
- A2B adenosine receptor blockade inhibits growth of prostate cancer cells
- (2013) Qiang Wei et al. Purinergic Signalling
- Purinergic signalling and cancer
- (2013) Geoffrey Burnstock et al. Purinergic Signalling
- Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
- (2013) Xiao-Xia Lu WORLD JOURNAL OF GASTROENTEROLOGY
- Adenosine and Prostaglandin E2 Production by Human Inducible Regulatory T Cells in Health and Disease
- (2013) Theresa L. Whiteside et al. Frontiers in Immunology
- A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
- (2013) Alberto L Horenstein et al. OncoImmunology
- Regulation of Macrophage Function by Adenosine
- (2012) György Haskó et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A3Adenosine Receptor Mediates Apoptosis in 5637 Human Bladder Cancer Cells by GqProtein/PKC-Dependent AIF Upregulation
- (2012) Takeshi Kanno et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Adenosine Induces Apoptosis in SBC-3 Human Lung Cancer Cells through A3Adenosine Receptor-Dependent AMID Upregulation
- (2012) Takeshi Kanno et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- CD73 and adenosine generation in the creation of regulatory microenvironments
- (2012) F. S. Regateiro et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The stimulation of A3 adenosine receptors reduces bone-residing breast cancer in a rat preclinical model
- (2012) Katia Varani et al. EUROPEAN JOURNAL OF CANCER
- CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
- (2012) Bertrand Allard et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- 5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells
- (2012) Claudia Quezada et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A3 Adenosine Receptor Mediates Apoptosis in In Vitro RCC4-VHL Human Renal Cancer Cells by Up-Regulating AMID Expression
- (2012) Hisao Nagaya et al. JOURNAL OF UROLOGY
- P2 receptors and immunity
- (2012) Amel Rayah et al. MICROBES AND INFECTION
- The Adenosine A3 Receptor Agonist Cl-IB-MECA Induces Cell Death Through Ca2+/ROS-Dependent Down Regulation of ERK and Akt in A172 Human Glioma Cells
- (2012) Thae Hyun Kim et al. NEUROCHEMICAL RESEARCH
- Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
- (2012) Rafael Fernandes Zanin et al. PLoS One
- Cellular function and molecular structure of ecto-nucleotidases
- (2012) Herbert Zimmermann et al. Purinergic Signalling
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway
- (2011) Mahmoud Aghaei et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
- (2010) K. M. Dwyer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- The minimal important difference of exercise tests in severe COPD
- (2010) M. A. Puhan et al. EUROPEAN RESPIRATORY JOURNAL
- Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells
- (2010) De-Fu Ma et al. HUMAN PATHOLOGY
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vitroinduction of T cells that are resistant to A2adenosine receptor-mediated immunosuppression
- (2009) Akio Ohta et al. BRITISH JOURNAL OF PHARMACOLOGY
- NK cell-mediated cytotoxicity modulation by A2 adenosine receptor agonist in different mammalian species
- (2009) M. Kuldová et al. FOLIA MICROBIOLOGICA
- Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-κB signalling pathway in thyroid cancer cells
- (2009) Silvana Morello et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adenosine Blocks IFN- -Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation
- (2009) K. E. Barnholt et al. JOURNAL OF IMMUNOLOGY
- Differential ectonucleotidase expression in human bladder cancer cell lines
- (2009) Joséli Stella et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Alternative Activation of Macrophages: An Immunologic Functional Perspective
- (2008) Fernando O. Martinez et al. Annual Review of Immunology
- Purinergic signalling: past, present and future
- (2008) G. Burnstock BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
- (2008) Dima L. Diab et al. Clinical Gastroenterology and Hepatology
- Adenosine and IFN-α synergistically increase IFN-γ production of human NK cells
- (2008) Florian Jeffe et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
- (2008) Luci Bavaresco et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started